eCardio launches eTrigger AF 920

eCardio Diagnostics, a provider of advanced ambulatory cardiac monitoring products and services launches the eTrigger AF920 event monitor for detection of atrial fibrillation (Afib) among asymptomatic patients. Unlike standard cardiac monitoring devices, eCardio Diagnostics eTrigger AF 920 is equipped with an embedded algorithm that automatically detects and records asymptomatic events without patient activation. This feature is especially valuable in diagnosing Afib as often times patients don’t feel symptoms during an Afib episode. Atrial fibrillation is the most common sustained heart rhythm disorder and increases the risk for heart disease and stroke, both leading causes of death in the United States. eCardio Diagnostics will showcase its new eTrigger AF920 Afib Monitoring device at Pri-Med MidWest in Chicago, June 15-17. In addition to the new eTriggerAF920 monitor, eCardio will feature its other best-in-class holter, patient-activated and post-event monitors.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video